The New Jersey Cannabis Regulatory Commission issued a request for proposals for its biannual assessment of the state's cannabis testing program, seeking what it describes as an independent, reproducible analysis of the testing program and the market integrity of cannabis products sold in New Jersey. The request states that proposals must be submitted no later than 3:00 p.m. ET on October 22, 2026, and that all costs must total $50,000 or less.
New Jersey cannabis regulator seeks independent analysis of state testing program
The New Jersey Cannabis Regulatory Commission issued a request for proposals for its biannual assessment of the state's cannabis testing program, seeking what it describes as an independent, reproducible analysis of the testing program and the market integrity of cannabis products sold in New Jersey. The request states that proposals must be submitted no later than 3:00 p.m. ET on October 22, 2026, and that all costs must total $50,000 or less.
The commission said regular statistical analysis of cannabis testing data is essential to ensure product safety, regulatory compliance, quality consistency, and the long-term success of New Jersey's legal cannabis market. It said accurate and consistent cannabis testing data is the foundation of consumer trust and regulatory adherence, and that analytics applied to lab results allow an understanding of how variables, such as the lab at which a test is performed, affect test outcomes.
According to the request, the analysis is intended to ensure that labs are detecting contaminants including pesticides, heavy metals, microbial organisms, and residual solvents that it says are invisible to the human senses. Without such analysis, the commission said, there is no verified way to confirm potency, composition, or safety, which it called a core requirement for state compliance. The commission also said testing helps ensure labs generate accurate and detailed Certificates of Analysis so products meet standards.
The commission said consistent analysis of compliance in a competitive and evolving testing laboratory market reduces the risk of product recalls and penalties and ensures public trust in legal cannabis products, and that it needs to ensure cannabis lab shopping is not taking place. The document also notes that lab shopping appears to result from a competitive market to test products. It said data analytics ensures cannabinoid and terpene profiles can be trusted by the public, which it called especially critical for medical cannabis, where it said dosage accuracy can affect patient outcomes.
The request sets applicant conditions: demonstrable experience with analysis of cannabis lab testing data across multiple states; good standing with the NJCRC and the Department of the Treasury; no appearance on the State of New Jersey Consolidated Debarment Report and no suspension or debarment by any other state or federal entity from receiving funds. Applicants must also have no conflict, or appearance of a conflict, between private interests and the official responsibilities of a person in a position of trust, which the request describes as including agency staff members, officers, and Governing Board Members.
Required deliverables include an executive summary presenting high-level findings suitable for leadership or legislative briefings; an academically rigorous report with detailed statistical analyses and visualizations and a section identifying data gaps and data quality issues; a reproducible analysis with annotated code used to generate all analyses and figures; and a regular meeting or check-in schedule with NJCRC staff. The commission said the full report would include an introduction and purpose, data sources and preparation, program overview, laboratory-level and market-level analysis, statistical signal detection, market integrity indicators, interpretation and regulatory context, recommendations and monitoring options, limitations and data gaps, and appendices covering code, methods, and documentation.
The source states that many New Jersey cannabis consumer advocates have been skeptical for years about the quality and the testing of legal cannabis in the state.
- The source does not identify the specific quality-control issues it says the assessment is meant to address.
- The source does not name the consumer advocates who have questioned the quality and testing of legal cannabis in the state, nor state their position in their own words.
- The source does not state whether any proposals have been submitted or how many assessments of this kind the commission has commissioned previously.
- The source does not state when a contract would begin, how long it would run, or how the biannual assessment schedule is timed.
- The source does not define what practices it means by cannabis lab shopping beyond the term itself.
- The source does not state whether the analysis would be made public or how its findings would be used in enforcement.